Standardization and Cross Validation of Alloreactive IFNγ ELISPOT Assays Within the Clinical Trials in Organ Transplantation Consortium

Solid Organ Allograft Survival Improvement in the United States: The Long-Term Does Not Mirror the Dramatic Short-Term Success

(2011) S. A. Lodhi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Monitoring tolerance and rejection in organ transplant recipients

(2011) Birgit Sawitzki et al.   BIOMARKERS

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

(2010) K. E. Lamb et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories

(2010) Dilbinder K. Gill et al.   PLoS One

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine

(2010) Emmanuel Morelon et al.   TRANSPLANT IMMUNOLOGY

Circulating Alloreactive T Cells Correlate with Graft Function in Longstanding Renal Transplant Recipients

(2008) O. Bestard et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Preferential Benefit of Antibody Induction Therapy in Kidney Recipients With High Pretransplant Frequencies of Donor-Reactive Interferon-γ Enzyme-Linked Immunosorbent Spots

(2008) Joshua J. Augustine et al.   TRANSPLANTATION